IISc's 3D Printer Unlocks Cancer Drug Secrets

Scientists at the Indian Institute of Science (IISc) have engineered a groundbreaking, 3D-printed device designed to simulate the challenging conditions within solid tumors. This low-cost innovation recreates the nutrient- and oxygen-deprived microenvironment characteristic of deeper tumor regions, enabling researchers to meticulously examine cancer cell responses to therapeutic drugs at different depths.

The newly developed platform addresses a persistent hurdle in cancer research by accurately replicating complex tumor conditions in a laboratory setting. Unlike traditional flat cell cultures, this device utilizes a press-fit enclosure made via FDM 3D printing to hold stacked paper discs, each containing embedded cancer cells. This setup allows for controlled diffusion of nutrients and oxygen, mirroring tumor depth and hypoxia.

Experiments using MDA-MB-231 breast cancer cells validated the model's effectiveness. The study observed a progressive decrease in live cells and an increase in dead cells from the surface to deeper layers, alongside elevated HIF-1alpha expression, confirming the hypoxic tumor-like environment. Furthermore, the research revealed declining doxorubicin penetration and drug uptake in deeper tumor regions, with longer treatment periods partially mitigating these diffusion limitations.

Published in Analytical Methods in 2026, the study also investigated the combined effects of doxorubicin and paclitaxel, finding an antagonistic interaction when administered together. The IISc team has made the device's design files publicly accessible, promoting wider adoption for drug screening and studies on treatment response, thereby making paper-supported 3D tumor models more attainable for laboratories worldwide.